Healthy School Recognized Campus: school physical activity and nutrition program
Official title: Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial
Run by Texas A&M University · NCT07079995 · Data updated 2026-11-12
This project will test whether the Healthy School Recognized Campus program and a mentoring approach help increase physical activity, healthy eating, and related health measures for 4th–9th grade students at public schools in Central and East Texas.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 16 Years |
| Sex | All |
| Enrollment | 900 (estimated) |
| Sponsor | Texas A&M University Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07079995 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are 4th–9th grade students enrolled at participating public schools in Central and East Texas who can read, speak, and write English and can complete physical assessments.
✕Probably not a fit
Students with motor or cognitive impairments or other health conditions that prevent completion of physical assessments, as well as students at schools not yet receiving HSRC because of randomization, may not receive direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a cluster dual randomized controlled trial enrolling 20 public schools in Central and East Texas that randomizes schools both to receive the Healthy School Recognized Campus (HSRC) intervention or a waitlist control and to receive a mentoring implementation program or standard implementation. Schools assigned to HSRC will deliver youth and adult physical activity and nutrition programs while waitlist schools continue their usual activities and receive HSRC the following year. Primary effectiveness outcomes include BMI z-score, physical activity, and skin carotenoids as a biomarker of fruit and vegetable intake, while implementation outcomes include acceptability, feasibility, number of students reached, and total program dosage. Students in grades 4–9 who can complete physical assessments and read, speak, and write English will be followed to measure both behavioral and health outcomes.
Why it matters
Potential benefit: If successful, the program could increase students' physical activity and fruit and vegetable intake and help prevent unhealthy weight gain across participating schools.
How similar studies have gone: Previous school-based physical activity and nutrition programs have shown modest improvements in activity levels and diet, but the combined dual randomized design testing both the program and a mentoring implementation strategy is less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
School Inclusion Criteria: * located in Central and East Texas * Public school Student Inclusion Criteria * enrolled in the 4th, 5th, 6th, 7th, 8th, or 9th grade * able to read, speak, and write in English Student Exclusion Criteria: * any motor or cognitive impairments or other health conditions that would prevent them from completing a physical assessment
Where it's running
-
Texas A&M AgriLife Dallas Center
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Jacob Szeszulski — Institute for Advancing Health through Agriculture
- Study coordinator: Jacob Szeszulski
- Email: jacob.szeszulski@agnet.tamu.edu
- Phone: 972-952-9202
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.